| # | Drug | Count |
|---|---|---|
| 0 | SUNITINIB MALATE | 26 |
| 1 | PAZOPANIB HYDROCHLORIDE | 19 |
| 2 | SORAFENIB | 16 |
| 3 | METOPROLOL TARTRATE | 13 |
| 4 | METOPROLOL | 11 |
| 5 | METOPROLOL TARTRATE INJECTION | 10 |
| 6 | OMEPRAZOLE MAGNESIUM | 10 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 9 |
| 8 | MESALAMINE | 9 |
| 9 | AXITINIB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 1 | 0.0055 |
| 1 | NALBUPHINE HYDROCHLORIDE | 1 | 0.0044 |
| 2 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 3 | SORAFENIB | 16 | 0.0008 |
| 4 | PAZOPANIB HYDROCHLORIDE | 19 | 0.0007 |
| 5 | SUNITINIB MALATE | 26 | 0.0007 |
| 6 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 7 | OMAVELOXOLONE | 1 | 0.0006 |
| 8 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 9 | SULINDAC | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 30 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 10 |
| 2 | Proton Pump Inhibitor [EPC] | 10 |
| 3 | Aminosalicylate [EPC] | 9 |
| 4 | Insulin Analog [EPC] | 8 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 8 |
| 7 | Benzodiazepine [EPC] | 6 |
| 8 | Corticosteroid [EPC] | 6 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 1 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 2 | Cannabinoid [EPC] | 1 | 0.0001 |
| 3 | Aminosalicylate [EPC] | 9 | 0.0001 |
| 4 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 5 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 6 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 7 | Kinase Inhibitor [EPC] | 30 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |